Boule Diagnostics wins strategic tender

Boule Diagnostics AB has won the tender to supply hematology instruments to the Västra Götaland Region in Sweden. The tender is for around 40 of the new Swelab Alfa Plus generation instruments and includes service, consumables and spare parts. Installation of the instruments is set to start in quarter two, 2017.

“That we have won yet another public tender on the tough Swedish market is an undoubted triumph. This follows a similar successful tender to supply Östergötland County Council. The fact that we are able to win such tenders in the face of intense international competition is further proof that our products meet exacting quality requirements, which will be of strategic importance in future procurement processes,” Ernst Westman, CEO and Group President, Boule Diagnostics, says.

For more information, please contact:
Ernst Westman, CEO and president, Boule Diagnostics AB, tel +46 708-60 88 63

About Boule Diagnostics AB

Boule Diagnostics AB is a fast-growing diagnostics company, developing and manufacturing systems and consumables for hematology diagnostics for the public healthcare providers worldwide. The company is primarily focused on small and medium-sized hospitals, clinics and laboratories in outpatient care as well as other diagnostics companies in both human and veterinary hematology. The group is comprised of operating subsidiaries in Sweden, the US and China. The Boule Diagnostics share is traded on NASDAQ Nordic since 2011.

This information is information that Boule Diagnostics AB is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the agency of the contact person set out above, at 08:45 CET on Mars 17, 2017.



  • Subscribe to our news